Challenges and Opportunities for Extracellular Vesicles in Clinical Oncology Therapy

Shuya Lu,Qingfa Cui,Huan Zheng,Yuan Ma,Yanchun Kang,Ke Tang
DOI: https://doi.org/10.3390/bioengineering10030325
IF: 5.046
2023-01-01
Bioengineering
Abstract:Extracellular vesicles (EVs) are membrane-bound vesicles that can be released by all cell types. They may have different biogenesis, physical features, and cargo. EVs are important biomarkers for the diagnosis and prediction of many diseases due to their essential role in intercellular communication, their highly variable cargoes, and their accumulation in various body fluids. These natural particles have been investigated as potential therapeutic materials for many diseases. In our previous studies, the clinical usage of tumor-cell-derived microparticles (T-MPs) as a novel medication delivery system was examined. This review summarizes the clinical translation of EVs and related clinical trials, aiming to provide suggestions for safer and more effective oncology therapeutic systems, particularly in biotherapeutic and immunotherapeutic systems.
What problem does this paper attempt to address?